Furthermore, from the IHC findings that showed both low levels of MRE11 and RAD50 were linked with higher grade tumours, the identification of aldo–keto reductase family in both RAD50 low and MRE11 low tumours highlights a role in tumour progression. Here, RAD50 is linked to neoplasm.